Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction
- PMID: 6243359
Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction
Abstract
Botulinum toxin-induced paralysis of neuromuscular transmission involves at least three steps. There is an initial binding step that is nontoxic, a translocation step that is nontoxic and a subsequent lytic step that produces blockade of transmission. In the absence of nerve stimulation, the binding step has a half-time of similar to or approximately 12 min and a rate constant of similar to or approximately 0.058 . min-1. The binding step does not require calcium or nerve stimulation, and it has a low temperature dependence (Q10 similar to or approximately 1.6). In the absence of nerve stimulation, the translocation step has a half-time of similar to or approximately 4.9 min and a rate constant of similar to or approximately 0.141 . min-1. Translocation requires physiological concentrations of calcium. In the virtual absence of nerve stimulation (1 x 10(-2) Hz), the lytic step has a half-time of similar to or approximately 55 min and a rate constant of similar to or approximately 0.013 . min-1. The lytic step requires calcium, is facillitated by nerve stimulation and has a high temperature dependence by nerve stimulation and has a high temperature dependence (Q10 similar to or approximately 4.2). These data are used to propose a model for botulinum toxin interaction with the cholinergic nerve terminal.
Similar articles
-
Neuromuscular activity of BaTX, a presynaptic basic PLA2 isolated from Bothrops alternatus snake venom.Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):291-7. doi: 10.1016/j.cbpc.2009.05.007. Epub 2009 May 20. Comp Biochem Physiol C Toxicol Pharmacol. 2009. PMID: 19463969
-
Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.J Pharmacol Exp Ther. 1983 Jan;224(1):135-40. J Pharmacol Exp Ther. 1983. PMID: 6294275
-
Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.J Pharmacol Exp Ther. 1991 Sep;258(3):830-6. J Pharmacol Exp Ther. 1991. PMID: 1653841
-
The action of batulinum toxin at the neuromuscular junction.Med Biol. 1981 Feb;59(1):11-20. Med Biol. 1981. PMID: 6115105 Review.
-
[Mechanisms of action of botulinum toxins and neurotoxins].Ann Dermatol Venereol. 2009 May;136 Suppl 4:S73-6. doi: 10.1016/S0151-9638(09)74531-4. Ann Dermatol Venereol. 2009. PMID: 19576489 Review. French.
Cited by
-
Kinetic and reaction pathway analysis in the application of botulinum toxin a for wound healing.J Toxicol. 2012;2012:159726. doi: 10.1155/2012/159726. Epub 2011 Nov 24. J Toxicol. 2012. PMID: 22174710 Free PMC article.
-
Botulinum toxin a inhibits acetylcholine release from cultured neurons in vitro.In Vitro Cell Dev Biol Anim. 1993 Jun;29(6):456-60. doi: 10.1007/BF02639379. In Vitro Cell Dev Biol Anim. 1993. PMID: 27519746
-
At least three sequential steps are involved in the tetanus toxin-induced block of neuromuscular transmission.Naunyn Schmiedebergs Arch Pharmacol. 1981;317(4):326-30. doi: 10.1007/BF00501314. Naunyn Schmiedebergs Arch Pharmacol. 1981. PMID: 6119629
-
Onset dynamics of type A botulinum neurotoxin-induced paralysis.J Pharmacokinet Pharmacodyn. 2008 Jun;35(3):251-67. doi: 10.1007/s10928-008-9087-3. Epub 2008 Jun 13. J Pharmacokinet Pharmacodyn. 2008. PMID: 18551355 Free PMC article.
-
Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms.Infect Immun. 1997 May;65(5):1626-30. doi: 10.1128/iai.65.5.1626-1630.1997. Infect Immun. 1997. PMID: 9125539 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous